Adobe
ADBE
Lennar Corp
LEN
Petroleo Brasileiro SA Petrobras
PBR
Apple
AAPL
D.R. Horton
DHI
US Stock MarketDetailed Quotes
RHHBY ROCHE HOLDING AG
- 35.000
- +0.040+0.11%
15min DelayClose Dec 26 16:00 ET
- 34.980
- -0.020-0.06%
Post 16:05 ET
223.10BMarket Cap19.04P/E (TTM)
35.120High34.710Low969.98KVolume34.730Open34.960Pre Close33.96MTurnover0.02%Turnover Ratio17.61P/E (Static)6.37BShares42.43052wk High6.93P/B223.10BFloat Cap29.20052wk Low1.36Dividend TTM6.37BShs Float49.895Historical High3.87%Div YieldTTM1.17%Amplitude-3.794Historical Low35.008Avg Price1Lot Size
ROCHE HOLDING AG News
RAPT Upgraded at H.C. Wainwright on China Licensing Deal
RAPT Rockets 180% on Licensing Deal, $150M Private Placement
Analysts Conflicted on These Healthcare Names: Verastem (VSTM), Roche Holding AG (OtherRHHVF) and Cabaletta Bio (CABA)
Health Care Down on Backlash Fears -- Health Care Roundup
Prothena Stock Gains 38% After Parkinson's Treatment Shows Potential Benefits
Roche's Prasinezumab Misses Goal in Parkinson's Disease Study
European Shares Fall as Fed Turns Hawkish on Rates Outlook
Here's Why VKTX Stock Plummeted 18% on Wednesday
Roche's Negative Parkinson Drug Results Don't Surprise -- Market Talk
Express News | Genentech's Prasinezumab Phase IIb Study Misses Primary Endpoint But Shows Potential In Early Parkinson's Disease
Roche Says Parkinson's Disease Drug Missed Main Goal of Phase 2b Trial
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Roche Gets CE Marking for Mass Spectrometry Tech
Roche Transforms Mass Spectrometry Diagnostics With Launch of Cobas Mass Spec Solution
Novo's New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way. -- Barrons.com
Sangamo Surges 24% After Roche Ends Development of Hemophilia A Gene Therapy
Roche Gets Approval for Vabysmo PFS in EU for Three Retinal Diseases
PepGen Stock Craters 35% on FDA Clinical Hold
Analysts Offer Insights on Healthcare Companies: Checkpoint Therapeutics (CKPT) and Roche Holding AG (OtherRHHVF)
Swiss Equities an Overweight Pick Next Year -- Market Talk
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
